Comprehensive multi-omic profiling of somatic mutations in malformations of cortical development
Malformations of cortical development (MCD) are neurological conditions involving focal disruptions of cortical architecture and cellular organization that arise during embryogenesis, largely from somatic mosaic mutations, and cause intractable epilepsy. Identifying the genetic causes of MCD has bee...
Saved in:
Published in | Nature genetics Vol. 55; no. 2; pp. 209 - 220 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Nature Publishing Group
01.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Malformations of cortical development (MCD) are neurological conditions involving focal disruptions of cortical architecture and cellular organization that arise during embryogenesis, largely from somatic mosaic mutations, and cause intractable epilepsy. Identifying the genetic causes of MCD has been a challenge, as mutations remain at low allelic fractions in brain tissue resected to treat condition-related epilepsy. Here we report a genetic landscape from 283 brain resections, identifying 69 mutated genes through intensive profiling of somatic mutations, combining whole-exome and targeted-amplicon sequencing with functional validation including in utero electroporation of mice and single-nucleus RNA sequencing. Genotype-phenotype correlation analysis elucidated specific MCD gene sets associated with distinct pathophysiological and clinical phenotypes. The unique single-cell level spatiotemporal expression patterns of mutated genes in control and patient brains indicate critical roles in excitatory neurogenic pools during brain development and in promoting neuronal hyperexcitability after birth. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC9961399 Full membership of the FCD Neurogenetic Consortium is listed at the end of this file C.C., X.Y., Sa.B., St.B., and J.G.G. designed the study. C.C., S.M., and S.K. conducted functional validation. C.B., V.S., A.S.N., E.R., C.C., and G.H. coordinated the clinical database. X.Y., C.C., M.W.B., L.L.B., R.D.G., J.G., M.X., A.P.L.M., and K.N.J. organized, handled, and sequenced human samples. X.Y., C.C., T.B., Y.W., A.A., X.X., Z.L., and B.C. performed bioinformatics and data analysis. C.C. and K.I.V. performed the RNAscope experiment. C.D., H.W.P., C.A.B.G., S.H.K., H.K., H.U., M.P., A.S., C.A.H., D.D.L., C.A.G., M.D.S., S.S., M.N., D.D.G., K.I., Y.T., H.C., J.T., V.C., R.G., O.D., W.A.S., H.R.M., and G.W.M. provided resected brain tissues and clinical data from FCD patients. C.C., X.Y., and J.G.G. wrote the manuscript. All authors read and commented on the manuscript before submission. Full membership of the Brain Somatic Mosaicism Network is listed at the end of this file These authors contributed equally Author contributions |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/s41588-022-01276-9 |